The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 5, 2011, Pages 915-921

  Krzystek Korpacka, Malgorzata ^a   Patryn, Eliza ^a   Kustrzeba Wojcicka, Irena ^a   Chrzanowska, Joanna ^a   Gamian, Andrzej ^a,b   Noczynska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW RESEARCH CENTRE EIT   (Poland)

Author keywords

adolescents; children; life style modification; metformin; obesity; uric acid; weight reduction

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ARTICLE; BODY MASS; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FOLLOW UP; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KINESIOTHERAPY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; THERAPY EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

ADOLESCENT; AGE FACTORS; CHILD; DIET; EXERCISE; FEMALE; HUMANS; MALE; METFORMIN; OBESITY; SEX FACTORS; TIME FACTORS; URIC ACID; WEIGHT LOSS;

EID: 79954456318     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.130     Document Type: Article

References (46)

1. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease and metabolic syndrome. Cleve Clin J Med 2006;73: 1059-64. (Pubitemid 44883981)
2. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-2. (Pubitemid 351213351)
3. Avram Z, Krishnan E. Hyperuricaemia-where nephrology meets rheumatology Rheumatology 2008;47:960-4.
4. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010;62:170-80.
5. Feig DI, Soletsky B, Johnson RJ. Randomized trial with newly diagnosed essential hypertension: an effect of Allopurinol on blood pressure of adolescents. J Am Med Assoc 2008;300: 924-32.
6. Higgins P, Dawson J, Walters M. The potential for xanthine oxidase inhibition in the prevention and treatment of cardio-vascular and cerebrovascular disease. Cardiovasc Psychiatry Neurol 2009;2009:282059.
7. Siu YP, Leung KT, Tong MK, Kwan TH Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006;47:51-9. (Pubitemid 41828266)
8. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glus-hakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290: F625-31. (Pubitemid 43724964)
9. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96. (Pubitemid 47235197)
10. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005;25:39-42. (Pubitemid 40128147)
11. Feig DI, Mazzali M, Kang D-H, Nakagawa T, Price K, Kannelis J, et al. Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol 2006;17:S69-73.
12. Gil-Campos M, Aguilera CM, Cañete R, Gil A. Uric acid is associated with features of insulin resistance syndrome in obese children at prepubertal stage. Nutr Hosp 2009;24:607-13.
13. Nguyen S, Choi HK, Lustig RH, Hsu CY Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009;154:807-13.
14. Park HS, Sim SJ, Park JY Effect of weight reduction on met-abolic syndrome in Korean obese patients. J Korean Med Sci 2004;19:202-8. (Pubitemid 38591792)
15. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86:899-906. (Pubitemid 47538288)
16. Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, Yamakado M, et al. Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individ-uals. J Rheumatol 2010;37:410-6.
17. Togashi K, Masuda H, Iguchi K. Effect of diet and exercise treatment for obese Japanese children on abdominal fat distri-bution. Res Sports Med 2010;18:62-70.
18. Krzystek-Korpacka M, Patryn E, Kustrzeba-Wojcicka I, Chrza-nowska J, Gamian A, Noczynska A. Gender-specific associa-tion of serum uric acid with metabolic syndrome and its components in juvenile obesity Clin Chem Lab Med 2011;49:129-36.
19. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey Br Med J 2000;320:1240-3. (Pubitemid 30240471)
20. Krzystek-Korpacka M, Patryn E, Boehm D, Berdowska I, Zie-linski B, Noczynska A. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and fol-lowing weight reduction. Clin Biochem 2008;41:943-9.
21. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a sci-entific statement from the American Heart Association Nutri-tion Committee. Circulation 2006;114:82-96. (Pubitemid 44305278)
22. Palczewska I, Niedzwiecka Z. Wskazniki rozwoju somatycz-nego dzieci i mlodziezy warszawskiej. (Indices of somatic development of children and adolescents in Warsaw). Med Wieku Rozw 2002;2(supl. I):52.
23. Cole TJ, Faith MS, Pietrobelli A, Heo M. What is the best measure of adiposity change in growing children: BMI, BMI%, BMI z-score or BMI centile? Eur J Clin Nutr 2005;59:419-25. (Pubitemid 40403297)
24. Nawarycz T, Ostrowska-Nawarycz L. Rozklady centylowe obwodu pasa u dzieci i mlodziezy (Centile charts of waist cir-cumference for children and adolescents). Pediatr Pol 2007; 82:418-24. (Pubitemid 350202113)
25. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76.
26. Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intra-and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997;35:845-52. (Pubitemid 27510862)
27. Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obe-sity Diabetes Obes Metab 2002;4:49-55. (Pubitemid 34285267)
28. De La Luz Martínez-Aguilar M, Flores-Peña Y, De Las Mercedes Rizo-Baeza M, Aguilar-Hernández RM, Vázquez-Galindo L, Gutiérres-Sánchez G 7th to 9th Grade Obese Adolescents' Per-ceptions About Obesity in Tamaulipas, Mexico. Rev. Latino-Am Enfermagem 2010; 18: 48-53.
29. Baughcum AE, Chamberlin LA, Deeks CM, Powers SW, Whi-taker RC. Maternal perceptions of overweight preschool chil-dren. Pediatrics 2000;106:1380-6.
30. Brener ND, Eaton DK, Lowry R, McManus T The association between weight perception and BMI among high school stu-dents. Obes Res 2004;12:1866-74. (Pubitemid 41133038)
31. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr 2008;152:817-22.
32. Franklin J, Denyer G, Steinbeck KS, Caterson ID, Hill AJ. Obe-sity and risk of low self-esteem: A statewide survey of Austra-lian children. Pediatrics 2006;118:2481-7. (Pubitemid 46397589)
33. Viner RM, Cole TJ. Who changes body mass between adoles-cence and adulthood? Factors predicting change in BMI between 16 year and 30 years in the 1970 British Birth Cohort. Int J Obes 2006;30:1368-74. (Pubitemid 44306519)
34. Rathmann W, Haastert B, Icks A, Giani G, Roseman JM. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study Eur J Epidemiol 2007;22:439-45. (Pubitemid 47224907)
35. Tetradze L, Virsaladze D, Javashvili L, Kilasonia L, Tananash-vili D. Relation of serum uric acid levels with basic metabolic parameters in patients with metabolic syndrome during insulin-sensitizing therapy. Georgian Med News 2007;151:44-7.
36. Barskova VG, Eliseev MS, Kudaeva FM, Aleksandrova EN, Volkov AV, Nasonova VA, et al. Effect of metformin on the clinical course of gout and insulin resistance. Klin Med 2009; 87:41-6.
37. Luque-Ramírez M, Alvarez-Blasco F, Uriol Rivera MG, Esco-bar-Morreale HF. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syn-drome: effect of treatment with ethinyl-estradiol plus cyprot-erone acetate versus metformin. Hum Reprod 2008;23:1594-601.
38. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Bren-neman AT, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 2009;374:1677-86.
39. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Econo-mou FN. Metformin: an old medication of new fashion: evolv-ing new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 2010;162:193-212.
40. Aubert G, Mansuy V, Voirol MJ, Pellerin L, Pralong FP. The anorexigenic effects of metformin involve increases in hypo-thalamic leptin receptor expression. Metabolism 2010 doi:10. 1016/j.metabol.2010.02.007.
41. Wilson DM, Abrams SH, Aye T, Lee PD, Lenders C, Lustig RH, et al. Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-con-trolled trial with 48-week follow-up. Arch Pediatr Adolesc Med 2010;164:116-23.
42. Ibáñez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity. J Pediatr 2010;156:98-102.e1.
43. Quinn SM, Baur LA, Garnett SP, Cowell CT. Treatment of clin-ical insulin resistance in children: a systematic review. Obes Rev 2010;11:722-30.
44. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endo-crinol Metab 2000;85:2767-74. (Pubitemid 32269149)
45. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003;44:527-36. (Pubitemid 41518990)
46. Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Lud-gate M. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 2010;95:722-30.